Cytokine Secretion in Colorectal Cancer Patients
Author Information
Author(s): H Lahm, M Schindel, L Frikart, J-P Cerottini, A Yilmaz, J-C Givel, JR Fischer
Primary Institution: Institute of Molecular Animal Breeding, Genecenter, University of Munich
Hypothesis
The study investigates the secretion of various cytokines in whole blood cell cultures of colorectal cancer patients compared to healthy controls.
Conclusion
Colorectal cancer patients exhibit significantly lower levels of certain cytokines, which correlates with disease progression.
Supporting Evidence
- Colorectal cancer patients secreted significantly lower amounts of IFN-a, IFN-y, IL-1 a, and IL-2 compared to healthy controls.
- The reduction in cytokine levels correlated with the progression of the disease.
- Lymphocyte counts were significantly lower in colorectal cancer patients, indicating a depletion of immune cells.
- Patients with advanced stages of cancer showed the most pronounced cytokine reductions.
Takeaway
Patients with colorectal cancer have lower levels of important immune signals called cytokines, which may be linked to how advanced their cancer is.
Methodology
Blood samples were taken from healthy volunteers and colorectal cancer patients, and cytokine levels were measured after mitogen stimulation in whole blood cell cultures.
Potential Biases
Potential bias may arise from the selection of control subjects and the specific patient population studied.
Limitations
The study does not account for potential confounding factors such as previous treatments or variations in individual immune responses.
Participant Demographics
28 colorectal cancer patients (17 male, 11 female) with a mean age of 67 years, and 4 healthy volunteers with a mean age of 52 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
33.50-77.45 for IFN-a; 16525-36268 for IFN-y; 43.01-124.66 for IL-1 a; 1314-2937 for IL-2
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website